The New Non-surgical Face-lift That Everyone’s Talking About!

By Addo Aesthetics, Published Originally Here

The latest non-surgical treatment is causing a stir in the aesthetics space, PDO ‘threads’ or ‘thread lifts’ – offer a less invasive option for those wanting a ‘lift’ in their skin.

Touted as a non-surgical solution for those considering everything from a facelift to rhinoplasty, the medical aesthetics market is on the rise, and minimally invasive procedures such as PDO thread lifts are the future of aesthetic regenerative medicine.

In the United States alone, the aesthetic PDO threads market size is expected to grow to $1.70B by 2028, at a compound annual growth rate (CAGR) of 2.36 percent.

So we caught up with PDO Max, Inc. President and Founder, Giovanna McCarthy to find out everything you need to know about PDO threads – and the benefits of adding these products to your client offering.

Why are PDO threads becoming a popular option?

As Giovanna explains, with an aging global population, people are looking for affordable and non-surgical options.

“People also want to look like themselves without seeing the fine lines and sagging skin,” she said.

“Threads are the answer because they do two things: they reposition the tissue to where it used to be 10-15 plus years-ago and they stimulate collagen. We start to lose collagen in our mid-twenties and it progresses significantly as we enter mid-life.”

According to the American Academy of Dermatology, collagen levels decline about 30 percent in women during the first five years of menopause. After that, women lose approximately two percent each year thereafter.

Creating a successful business in PDO threads

It was in 2014 after spending time in Italy alongside top plastic surgeons that Giovanna recognized that threads are an innovative procedure that would fill a void in the U.S. aesthetic market.

She then began conducting substantive research and review of the literature to determine the best thread and barb designs, searching high and low to partner with an ISO-certified manufacturing plant in South Korea to create her thread designs. The company now offers FDA-cleared threads inside cannulas in various sizes, designs, and types of threads, with products for both medical professionals and aestheticians.

It was from here that PDO Max was created in 2017, as a women-founded company, and two years later, the company became one of a few companies with fully FDA-cleared PDO thread-in-cannula devices.

PDO Max is based in Syracuse, New York with approximately 40 employees that represent research and development, clinical development, training, customer service, marketing, sales representatives, and warehouse distribution.

The company has grown a whopping 400 percent since it began selling PDO threads in 2020, and with PDO threads as an established procedure in the aesthetic “tool kit” PDO Max is now training approximately 30 practitioners each month who are keen to add threads to their procedure repertoire.

Giovanna is a Licensed Cosmetologist who has been in the skincare business for over 30 years and has tapped into the market for this innovative aesthetics procedure.

“We are seeing growth in sales not only because people are seeing the results with our PDO threads but because we are constantly listening to our customers’ needs and developing new ways to improve the designs and provide a tool that hasn’t been offered yet,” Giovanna said.

Seeing the popularity and results of PDO threads, PDO Max launched a topical liquid version of PDO at the end of 2022.

“I knew the regenerative power of threads and I knew there was another way to administer the treatment topically that focused more on hydrating and plumping the skin without the bruising,” she said.

As Giovanna explains, PDO Max’s focus is making practitioners confident in performing PDO thread procedures and understanding the regenerative and rejuvenating qualities of PDO.

“We do this by offering one-on-one training where we guide your hands to show you the best techniques to get the most optimal results for patients. We cover the history, science, indications, contraindications, risks, and possible complications.”